Merck wins China approval for lower respiratory tract infection treatment targeting infants, newborns. The drug is the first of its kind approved in the country for this age group.
Merck received approval in China for a lower respiratory tract infection treatment for infants and newborns.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near China
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
China launches three-year plan to cut energy use, carbon emissions in steel, cement, coal power and six other heavy industries, NDRC says. The plan targets upgrades through 2028 to support Beijing's 2030 carbon-peaking goal.
China has launched a three-year action plan to cut energy use and carbon emissions in nine high-energy-consuming industries, including steel, cement, and coal-fired power, according to the National Development and Reform Commission.
China bonds emerge as surprise haven as Iran war reshapes portfolios, Reuters reports
China bonds emerge as a surprise haven as the Iran war reshapes investment portfolios, according to Reuters.
6.3-magnitude earthquake hits Mindanao, Philippines, GFZ reports. The quake struck at 0918 GMT Monday at a depth of 116.8 km.
A 6.3-magnitude earthquake struck Mindanao, Philippines, at 0918 GMT on Monday, according to the GFZ German Research Center for Geosciences. The epicenter was at a depth of 116.8 km, initially determined at 6.14 degrees north latitude and 126.85 degrees east longitude.
Two pilots killed in Pakistan Air Force training plane crash, Xinhua reports.
In Pakistan, two pilots were killed in the crash of a training aircraft of the Air Force, reports Xinhua.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.